Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Treace Medical Concepts Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
TMCI
Nasdaq
3841
https://www.treace.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Treace Medical Concepts Inc
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
- Apr 24th, 2024 11:00 am
Treace to Present at Bank of America Health Care Conference
- Apr 17th, 2024 11:00 am
Treace Announces First Annual National Bunion Day
- Apr 16th, 2024 11:00 am
Treace to Report First Quarter 2024 Financial Results
- Apr 9th, 2024 11:00 am
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
- Mar 25th, 2024 11:00 am
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price Targets
- Mar 1st, 2024 10:50 am
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 1:43 pm
Treace Medical Concepts Full Year 2023 Earnings: EPS Misses Expectations
- Feb 29th, 2024 10:12 am
Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
- Feb 27th, 2024 11:35 pm
Treace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ...
- Feb 27th, 2024 9:40 pm
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
- Feb 27th, 2024 9:05 pm
Earnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to Decline
- Feb 20th, 2024 3:00 pm
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
- Feb 7th, 2024 9:05 pm
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
- Feb 2nd, 2024 5:00 pm
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
- Feb 1st, 2024 12:00 pm
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
- Jan 8th, 2024 12:00 pm
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Dec 19th, 2023 12:00 pm
Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)?
- Dec 7th, 2023 11:27 am
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2023 Earnings Call Transcript
- Nov 12th, 2023 5:22 pm
Q3 2023 Treace Medical Concepts Inc Earnings Call
- Nov 10th, 2023 2:13 pm
Scroll